Alere Inc logo

ALR - Alere Inc Share Price

$50.99 0.0  0.0%

Last Trade - 02/10/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £1.79bn
Position in Universe th / 6416
Bullish
Bearish
Unlock ALR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ALR Revenue Unlock ALR Revenue

Net Income

ALR Net Income Unlock ALR Revenue

Normalised EPS

ALR Normalised EPS Unlock ALR Revenue

PE Ratio Range

ALR PE Ratio Range Unlock ALR Revenue

Dividend Yield Range

ALR Dividend Yield Range Unlock ALR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ALR EPS Forecasts Unlock ALR Revenue
Profile Summary

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Directors
Last Annual December 31st, 2016
Last Interim June 30th, 2017
Incorporated May 11, 2001
No. of Shareholders: 886
No. of Employees: 9,700
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange New York Stock Exchange
Shares in Issue 87,577,345
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ALR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to ALR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.